Cilt 11 / No:
9 - 10 / Eylül - Ekim 1998
TANI VE TEDAVİ
AKCİĞER TÜBERKÜLOZU (POST PRİMER TÜBERKÜLOZ)
Albayram, Canan Akman
ÇOK İLACA DİRENÇLİ
DİREKT GÖZETİM ALTINDA TEDAVİ
Günseli Kılınç Yılmaz
Tuberculosis (TB)is an ancient
disease that has long been a major public health problem. Although a highly
effective treatment exists, TB still kills nearly two to three million
people each year. The main reason for this paradox seems to be the low
political priority in TBcontrol especially in poor countries. The World
Health Organization-recommended TBtreatment strategy-DOTS(Directly Observed
Treatment, Short-Course)-has proven successful in every part of the world
and is considered to be a cost-effective intervention. The elements of
DOTS strategy are political will, reliable diagnosis using microscopes,
an adequate drug supply, health and community workers or trained volunteers
observing patients swallowing their medicines, and a system of recording
and reporting patients progress.
The following TBfacts reported
by WHO put into forth how alarming the situation is:
* TB kills more youth and
adults than any other infectious disease.
* This year, two to three
million people will die of TB.
* At least one person is
newly infected with TBevery second.
* Someone dies of TB every
* One perfect of the worlds
population is infected with TBeach year.
* One-third of the worlds
population is infected with the TBbacillus.
* Left untreated, a person
with active TBcan infect between 10 and 15 people in one year.
* Like the common cold,
TB spreads though the air when infectious people cough, talk or sneeze.
* Up to 50 million people
may be infected with drug-resistant TB.
* There is no cure affordable
to developing countries for some multidrug-resistant strains.
This issue of Klinik Gelişim
has been dedicated to this very important health problem and I hope the
topics chosen will draw the attention of not only the pulmonary physicians
but all the specialties.